AD Pharma

Global Drugs For Herpes Labialis (Oral Herpes) Consumption 2016 (Valacyclovir, Aciclovir, Famciclovir, Docosanol and Other) capacity, production, revenue, price, cost, gross margin, consumption value, sales and key companies profile

Press Release   •   Feb 10, 2017 09:57 EET

The global drugs for herpes labialis (oral herpes) market research report 2016 is a professional and in-depth study on the current state of the drugs for herpes labialis (oral herpes) market. Annual estimates and forecasts are provided for the period 2015 through 2021. Also, a six-year historic analysis is provided for these markets. The global market for drugs for herpes labialis (oral herpes) is expected to reach about 5460 M USD by 2021 from 1920 M USD in 2016, registering a compounded annual growth rate (CARG) of 5.1% during the analysis period, 2016-2021.

This report studies sale of Global Drugs for Derpes Labialis (oral herpes) Market 2016, especially in North America, Europe, China, Rest of Asia, focuses on top players in these regions, with revenue and market share for each player in these regions, covering

GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher

Market Segment by regions, this report splits global into several key regions, with sales (consumption), revenue, and market share and growth rate of drugs for herpes labialis (oral herpes) in these regions, from 2011 to 2021 (forecast), like

North America
Europe
China
Rest of Asia

Request more information at http://globalqyresearch.com/download-sample/159753 

Split by product types, with Sales, Revenue, Price, and market share and growth rate of each type, can be divided into

Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other

Split by applications, this report focuses on sales, market share and growth rate of drugs for herpes labialis (oral herpes) in each application, can be divided into

External Use
Oral
Injection

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market

View full report at http://globalqyresearch.com/global-drugs-for-herpes-labialis-oral-herpes-consumption-2016

Table of Contents

1 Drugs for Herpes Labialis (Oral Herpes) Overview 1
1.1 Product Overview and Scope of Drugs for Herpes Labialis (Oral Herpes) 1
1.1.1 Definition of Drugs for Herpes Labialis (Oral Herpes) 1
1.1.2 Specifications of Drugs for Herpes Labialis (Oral Herpes) 2
1.2 Classification of Drugs for Herpes Labialis (Oral Herpes) 3
1.2.1 Valacyclovir 4
1.2.2 Aciclovir 4
1.2.3 Famciclovir 5
1.2.4 Docosanol 6
1.3 Applications of Drugs for Herpes Labialis (Oral Herpes) 7
1.3.1 External Use 8
1.3.2 Oral 8
1.3.3 Injection 9
1.4 Drugs for Herpes Labialis (Oral Herpes) Market by Regions 10
1.4.1 North America Status and Prospect (2011-2021) 10
1.4.2 Europe Status and Prospect (2011-2021) 11
1.4.3 China Status and Prospect (2011-2021) 11
1.4.4 Rest of Asia Status and Prospect (2011-2021) 12
1.5 Global Market Size (Value) of Drugs for Herpes Labialis (Oral Herpes) (2011-2021) 12
1.5.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2011-2021) 12
1.5.2 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2021) 13
1.5.3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2021) 14
2 Global Drugs for Herpes Labialis (Oral Herpes) Competition by Manufacturers, Type and Application 15
2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Competition by Manufacturers 15
2.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share of Key Manufacturers (2015-2016) 15
2.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Share by Manufacturers (2015-2016) 18
2.2 Global Drugs for Herpes Labialis (Oral Herpes) (Volume and Value) by Type 21
2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share by Type (2011-2016) 21
2.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type (2011-2016) 23
2.3 Global Drugs for Herpes Labialis (Oral Herpes) (Volume and Value) by Regions 25
2.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share by Regions (2011-2016) 25
2.3.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Regions (2011-2016) 27
2.4 Global Drugs for Herpes Labialis (Oral Herpes) (Volume) by Application 29
3 North America Drugs for Herpes Labialis (Oral Herpes) (Volume, Value and Gross Price) 31
3.1 North America Drugs for Herpes Labialis (Oral Herpes) Gross and Value (2011-2016) 31
3.1.1 North America Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 31
3.1.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 32
3.1.3 North America Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 33
3.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturers 33
3.3 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type 34
3.4 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Applications 35
4 China Drugs for Herpes Labialis (Oral Herpes) (Volume, Value and Gross Price) 36
4.1 China Drugs for Herpes Labialis (Oral Herpes) Gross and Value (2011-2016) 36
4.1.1 China Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 36
4.1.2 China Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 37
4.1.3 China Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 38
4.2 China Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturers 38
4.3 China Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type 39
4.4 China Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Applications 40
5 Europe Drugs for Herpes Labialis (Oral Herpes) (Volume, Value and Gross Price) 41
5.1 Europe Drugs for Herpes Labialis (Oral Herpes) Gross and Value (2011-2016) 41
5.1.1 Europe Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 41
5.1.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 42
5.1.3 Europe Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 43
5.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturers 43
5.3 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type 44
5.4 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Applications 45
6 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) (Volume, Value and Gross Price) 46
6.1 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Gross and Value (2011-2016) 46
6.1.1 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 46
6.1.2 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 47
6.1.3 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 48
6.2 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturers 48
6.3 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type 49
6.4 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Applications 50
7 Analysis of Drugs for Herpes Labialis (Oral Herpes) Industry Key Manufacturers 51
7.1 GSK 51
7.1.1 Company Profile 51
7.1.2 Product Information 52
7.1.3 Revenue, Cost, Gross, and Gross Margin 53
7.2 Novartis 54
7.2.1 Company Profile 54
7.2.2 Product Information 55
7.2.3 Revenue, Cost, Gross, and Gross Margin 55
7.3 Teva 56
7.3.1 Company Profile 56
7.3.2 Product Information 57
7.3.3 Revenue, Cost, Gross, and Gross Margin 59
7.4 Mylan 59
7.4.1 Company Profile 59
7.4.2 Product Information 60
7.4.3 Revenue, Cost, Gross, and Gross Margin 62
7.5 Cadila 62
7.5.1 Company Profile 62
7.5.2 Product Information 63
7.5.3 Revenue, Cost, Gross, and Gross Margin 64
7.6 Apotex 64
7.6.1 Company Profile 64
7.6.2 Product Information 65
7.6.3 Revenue, Cost, Gross, and Gross Margin 66
7.7 Daewoong 66
7.7.1 Company Profile 66
7.7.2 Product Information 67
7.7.3 Revenue, Cost, Gross, and Gross Margin 68
7.8 Livzon 68
7.8.1 Company Profile 68
7.8.2 Product Information 69
7.8.3 Revenue, Cost, Gross, and Gross Margin 70
7.9 Luoxin 70
7.9.1 Company Profile 70
7.9.2 Product Information 72
7.9.3 Revenue, Cost, Gross, and Gross Margin 72
7.10 Med shine 73
7.10.1 Company Profile 73
7.10.2 Product Information 74
7.10.3 Revenue, Cost, Gross, and Gross Margin 74
7.11 Bayer (Campho Phenique) 75
7.11.1 Company Profile 75
7.11.2 Product Information 76
7.11.3 Revenue, Cost, Gross, and Gross Margin 76
7.12 Blistex 77
7.12.1 Company Profile 77
7.12.2 Product Information 78
7.12.3 Revenue, Cost, Gross, and Gross Margin 78
7.13 Kelun Group 79
7.13.1 Company Profile 79
7.13.2 Product Information 80
7.13.3 Revenue, Cost, Gross, and Gross Margin 80
7.14 Hikma 81
7.14.1 Company Profile 81
7.14.2 Product Information 82
7.14.3 Revenue, Cost, Gross, and Gross Margin 82
7.15 Haiwang 82
7.15.1 Company Profile 82
7.15.2 Product Information 83
7.15.3 Revenue, Cost, Gross, and Gross Margin 84
7.16 Carmex 84
7.16.1 Company Profile 84
7.16.2 Product Information 85
7.16.3 Revenue, Cost, Gross, and Gross Margin 85
7.17 Cipher 86
7.17.1 Company Profile 86
7.17.2 Product Information 87
7.17.3 Revenue, Cost, Gross, and Gross Margin 87
8 Drugs for Herpes Labialis (Oral Herpes) Manufacturing Cost Analysis 88
8.1 Drugs for Herpes Labialis (Oral Herpes) Key Raw Materials and Manufacturing Equipment Analysis 88
8.1.1 Drugs for Herpes Labialis (Oral Herpes) Key Raw Materials Analysis 88
8.1.2 Drugs for Herpes Labialis (Oral Herpes) Key Manufacturing Equipment Analysis 89
8.2 Proportion of Manufacturing Cost Structure 91
8.2.1 Raw Materials 91
8.2.2 Labor Cost Analysis of Drugs for Herpes Labialis (Oral Herpes) 91
8.2.3 Other Costs Analysis 98
8.3 Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes) 103
9 Industrial Chain, Sourcing Strategy and Downstream Buyers 104
9.1 Drugs for Herpes Labialis (Oral Herpes) Industrial Chain Analysis 104
9.2 Upstream Raw Materials Sourcing 104
9.3 Raw Materials Sources of Drugs for Herpes Labialis (Oral Herpes) Major Manufacturers 105
9.4 Downstream Buyers 106
10 Marketing Strategy Analysis, Distributors/Traders 108
10.1 Marketing Channel 108
10.2 Market Positioning 109
10.2.1 Pricing Strategy 109
10.2.2 Brand Strategy 109
10.2.3 Target Client 109
10.3 Distributors/Traders List 109
11 Market Effect Factors Analysis 111
11.1 Market Drivers 111
11.2 Consumer Needs/Customer Preference Change 111
11.3 Economic/Political Environmental Change 111
11.3.1 Global Economy Analysis 112
11.3.2 Europe Economy Analysis 113
11.3.3 Japan Economy Analysis 114
11.3.4 China Economy Analysis 115
11.3.5 USA Economy Analysis 117
12 Global Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2016-2021) 118
12.1 Global Drugs for Herpes Labialis (Oral Herpes) Gross, Revenue Forecast (2016-2021) 118
12.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Regions (2016-2021) 119
12.3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Type (2016-2021) 120
12.4 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Application (2016-2021) 120
13 Conclusion of the Global Drugs for Herpes Labialis (Oral Herpes) Market Report 2016 121
14 Appendix 122

To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/159753

About Us:

Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 32392407

Email: sales@globalqyresearch.com

Follow us:https://www.linkedin.com/company/global-qy-research

Twitter: https://twitter.com/gqyresearch